The ability of cancer to establish itself in distant parts of the body — called metastasis — causes 90% of
Month: April 2019
Experimental drug delivers one-two punch to vision loss
In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may
New imaging reveals previously unseen vulnerabilities of HIV
Imagine that HIV is a sealed tin can: if you opened it, what would you find inside? An international team
Experimental PET scan detects abnormal tau protein in brains of living former NFL players
(Boston) — Using an experimental positron emission tomography (PET) scan, researchers have found elevated amounts of abnormal tau protein in
Releasing an immune system brake could help patients with rare but fatal brain infection
The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically
A fungus, an antibiotic, a parasite, and a cure
Researchers have turned a fungus into a disease-curing factory through modern genetic engineering and patience. The natural antibiotic is a
Research reveals how the most common ALS mutation dooms cells
St. Jude Children’s Research Hospital scientists have cracked the mystery surrounding the most common genetic cause of amyotrophic lateral sclerosis
Biochemical switches identified that could be triggered to treat muscle, brain disorders
St. Jude Children’s Research Hospital scientists have found that the enzymes ULK1 and ULK2 play a key role in breaking
Anti-inflammatory medicine can have a beneficial effect on depression
Up to fifteen per cent of the Danish population will develop symptoms of depression at some point in their lives. The
The protein p38gamma identified as a new therapeutic target in liver cancer
An enzyme involved in cell stress responses could become a new pharmacological target in the treatment of liver cancer, a
